Our Services

Transplant Survival Rates

The Hillman Center for Pediatric Transplantation at Children’s Hospital of Pittsburgh of UPMC has performed more pediatric transplants than any other pediatric transplant center. Our transplant survival rates consistently beat the national average and are among the world’s best.

Transplant Survival Rates*

Liver Transplant Survival

1 Year 98% national average 94%
3 Years 96% national average 90%


Children’s Hospital of Pittsburgh has performed more than 1,600 pediatric liver transplants in children to date, making it the most active pediatric liver transplant center in the country.


Intestine Transplant Survival

1 Year 83% national average 79%
3 Years 91% national average 67%


Children's Hospital has performed more pediatric intestinal transplants than any other center in the country. Patients of Children’s pediatric intestinal transplant program represent the world’s first and most successful series of small intestine transplants.


Heart Transplant Survival

1 Year 100% national average 91%
3 Years 82% national average 83%

Our transplant team has performed more than 300 thoracic organ transplants in children to date, including more than 200 pediatric heart transplants, making it one of the most active pediatric transplant centers in the world.


Lung Transplant Survival

1 year 100% national average 84%
3 Years 80% national average 65%

Our transplant team performs double- and single-lung transplants for children suffering from lung disease including cystic fibrosis and pulmonary hypertension.


Heart-Lung Transplant Survival

Patients transplanted 2006-2010 76%

Children's Hospital performed the first successful pediatric heart-lung transplant in 1985. Since then our team has performed more pediatric heart-lung transplants than any other center in the country.


Kidney Transplant Survival

1 Year 100% national average 99%
3 Years 98% national average 98%

Children's transplant team has performed kidney transplants on hundreds of children and teens, making it one of the most active pediatric kidney transplant centers in the world.


Blood and Bone Marrow Transplant Survival (2008-March 2012)

Outcome Measure Type Children's Hospital
100-Day Survival 1 All** 91%
Myeloid Engraftment 2 Cord Blood 100% 
One-Year Overall Survival 3 All** 77%


1 Percentage of patients living one hundred or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)

2 Signs that the new bone marrow or stem cells are engrafting (growing and developing)

3 Percentage of patients living one or more years following the transplant procedure

* Sources: Internal data; Scientific Registry of Transplant Recipients (www.strt.org) July 2012 release

** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.

Blood and Marrow Transplantation (BMT) is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at Children's is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).

Last Update
September 12, 2013
  • Increase/Decrease Text Size
  • Print This Page
Last Update
September 12, 2013